Be Well™ Baytown, an initiative of The University of Texas MD Anderson Cancer Center sponsored by ExxonMobil, is calling on ...

Tens of thousands of Americans have relied on MD Anderson in Houston to care for their loved one, especially when a cancer ...

A federal judge on Tuesday temporarily blocked the White House from enacting a sweeping pause on federal grants and loans as ...

A phase 2 trial finds that for patients with HER2+ metastatic colorectal cancer, dual HER2-inhibitor therapy can be a similarly efficacious but less toxic alternative to EGFR inhibitor therapy.

Meetings designed to distribute grant money to fund research were canceled as part of a communications freeze at health ...

Rice University chemist and director of the university’s Synthesis X Center Han Xiao and cancer biologist Dihua Yu of The ...

Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefited from first-line treatment with the ...

AmMax Bio, Inc. (“AmMax”), a private clinical-stage biopharmaceutical company developing innovative therapeutics in oncology, today announced the dosing of the first patient in its Phase 2a study ...